Skip to main content
. 2009 Oct 6;12(Suppl 1):S4. doi: 10.1186/1758-2652-12-S1-S4

Figure 4.

Figure 4

Cumulative probability of treatment failure ddI-EC+FTC+ATV. Source: Campbell, T et al. ACTG A5175: a multinational study of ddI-EC, FTC and atazanavir vs. co-formulated AZT/3TC and efavirenz for initial treatment of HIV-1 infection. (THAB0404)